Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | ESR1 | P03372 | 2/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.34 |
| ▸ | CES2 | O00748 | 3/20 | 0.33 |
| ▸ | CES1 | P23141 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | NCOA2 | Q15596 | 1/20 | 0.33 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6957948 | 0.80 | NAAA (0.36) | TP53PSIP1CES2CES1ALDH1A1 | |
| SCHEMBL3971800 | 0.79 | MAPT (0.39) | TP53PSIP1MAPTESR1ESR2 | |
| SCHEMBL6049738 | 0.77 | MAPT (0.38) | TP53PSIP1MAPTESR1ESR2 | |
| SCHEMBL6963975 | 0.77 | SMN1; SMN2 (0.41) | MAPTCES2CES1ALDH1A1NPSR1 | |
| SCHEMBL9323038 | 0.75 | TP53 (0.35) | TP53PSIP1MAPTESR1ESR2 | |
| SCHEMBL6965425 | 0.75 | EPHX2 (0.42) | CES2CES1ALDH1A1SMN1; SMN2HPGD | |
| SCHEMBL988676 | 0.75 | NR1H2 (0.43) | TP53PSIP1MAPTESR1ESR2 | |
| SCHEMBL6972289 | 0.73 | EPHX2 (0.44) | CES2CES1ALDH1A1SMN1; SMN2 | |
| SCHEMBL2444645 | 0.72 | ESR1 (0.56) | TP53PSIP1MAPTESR1ESR2 | |
| SCHEMBL3889977 | 0.72 | TP53 (0.41) | TP53PSIP1MAPTESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240132675-A1 | POLYMER HAVING METAL-OXYGEN-METAL BOND AS PRIMARY CHAIN, COMPOSITION THEREOF, SOLID MATERIAL AND PRODUCTION METHOD THEREOF, AND ELECTRONIC COMPONENT AND FIBER | TORAY INDUSTRIES, INC. (JP) | 2024-04-25 | — | — | US | disclosed |
| US-20240002607-A1 | POLYMETALLOXANE, COMPOSITION OF SAME, CURED FILM, METHOD OF PRODUCING THE CURED FILM, MEMBER AND ELECTRONIC COMPONENT EACH PROVIDED WITH THE CURED FILM, FIBER, AND METHOD OF PRODUCING THE FIBER | TORAY INDUSTRIES, INC. (JP) | 2024-01-04 | — | — | US | disclosed |
| US-11795064-B2 | Polymetalloxane, method for producing same, composition thereof, cured film and method for producing same, and members and electronic components provided with same | TORAY INDUSTRIES, INC. (JP) | 2023-10-24 | — | — | US | disclosed |
| US-20230331927-A1 | POLYMETALLOXANE-CONTAINING COMPOSITION, CURED BODY, MEMBER, ELECTRONIC COMPONENT, AND FIBER | TORAY INDUSTRIES, INC. (JP) | 2023-10-19 | — | — | US | disclosed |
| WO-2022202398-A1 | POLYMER HAVING METAL-OXYGEN-METAL BOND AS PRIMARY CHAIN, COMPOSITION THEREOF, SOLID MATERIAL AND PRODUCTION METHOD THEREOF, AND ELECTRONIC COMPONENT AND FIBER | 東レ株式会社 | 2022-09-29 | — | — | WO | disclosed |
| US-20210108339-A1 | METHOD FOR PRODUCING METAL OXIDE FIBERS, AND METAL OXIDE FIBERS | TORAY INDUSTRIES, INC. (JP) | 2021-04-15 | — | — | US | disclosed |
| EP-3779001-A1 | METHOD FOR PRODUCING METAL OXIDE FIBERS, AND METAL OXIDE FIBERS | Toray Industries, Inc. (JP) | 2021-02-17 | — | — | EP | disclosed |
| CN-106146851-B | Photocurable composition and cured product containing same | 信越化学工业株式会社 | 2020-10-23 | — | — | CN | disclosed |
| EP-3381969-B1 | POLYMETALLOXANE, METHOD FOR PRODUCING SAME, COMPOSITION THEREOF, CURED FILM AND METHOD FOR PRODUCING SAME, AND MEMBERS AND ELECTRONIC COMPONENTS PROVIDED WITH SAME | TORAY INDUSTRIES (JP) | 2020-06-03 | — | — | EP | disclosed |
| EP-3093303-B1 | PHOTOCURABLE COMPOSITION AND CURED PRODUCT | SHINETSU CHEMICAL CO (JP) | 2019-08-28 | — | — | EP | disclosed |
| US-5514419-A | POLYDIMETHYLSILOXANE, POLYISOBUTYLENE OLIGOMER | DOW CORNING CORPORATION (US) | 1996-05-07 | — | — | US | disclosed |
| US-5508270-A | Nucleoside phosphinate compounds and compositions | CIBA-GEIGY CORPORATION (US) | 1996-04-16 | — | — | US | disclosed |
| US-5507960-A | SURFACE TREATED WITH A BLEND OF A POLYDIMETHYLSILOXANE AND A POLYISOBUTYLENE OLIGOMER; SURFACE GLOSS IS SLIGHTLY ENHANCED | DOW CORNING CORPORATION (US) | 1996-04-16 | — | — | US | disclosed |
| EP-0705884-A2 | Method for treating plastic, leather or rubber substrates | DOW CORNING CORPORATION (US) | 1996-04-10 | — | — | EP | disclosed |
| EP-0705631-A2 | Epoxy-terminated polyisobutylene polydimethylsiloxane compositions | DOW CORNING CORPORATION (US) | 1996-04-10 | — | — | EP | disclosed |
| EP-0705632-A2 | 2-Methylpropenyl-terminated polyisobutylene-polydimethyl-siloxane compositions | DOW CORNING CORPORATION (US) | 1996-04-10 | — | — | EP | disclosed |
| US-5466677-A | Dinucleoside phosphinates and their pharmaceutical compositions | CIBA-GEIGY CORPORATION (US) | 1995-11-14 | — | — | US | disclosed |
| US-5442010-A | Antifoam agents | DOW CORNING CORPORATION (US) | 1995-08-15 | — | — | US | disclosed |
| EP-0614906-A1 | Mononucleotide analogues and intermediates therefor | CIBA-GEIGY AG (CH) | 1994-09-14 | — | — | EP | disclosed |
| EP-0614907-A1 | Dinucleotide and oligonucleotide analogues | CIBA-GEIGY AG (CH) | 1994-09-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11795064-B2 | Polymetalloxane, method for producing same, composition thereof, cured film and method for producing same, and members and electronic components provided with same | ASH2L, SETDB1, BMI1 | TP53 2420/4885PSIP1 1334/4885MAPT 1602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.